Urovant Sciences Ltd. (26) | Uncategorized (3)
- Co-Promotion Agreement, dated October 6, 2020, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
- Letter Agreement, dated October 31, 2019, by and between Sumitomo Dainippon Pharma Co., Ltd. and Urovant Sciences Ltd (Filed With SEC on October 31, 2019)
- Description of Securities (Filed With SEC on June 14, 2019)
